Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ramesh Hariharan

Clinical Cardiac Electrophysiology Houston, TX Medical Doctor

NPI 1770509168 CMS profile 35094

6400 Fannin St Ste 2550, Ste 470, Houston, TX 77030

Open in the dashboard

General payments

$165,310

944 records reported · program years 2019–2025

Research payments

$6,384

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$627,752 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ramesh Hariharan of Houston, TX is reported in the CMS Open Payments database as having received $165,310 across 944 general payments and $6,384 in research payments paid to them. Separately, studies naming them as principal investigator received $627,752 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,094 93
2025 Research $6,384 1
2024 General $6,346 119
2023 General $9,564 161
2022 General $5,790 190
2021 General $43,399 148
2020 General $39,608 86
2019 General $47,509 147

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ramesh Hariharan
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Ramesh Hariharan were reported at $13,094. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Ramesh Hariharan Clinical Cardiac Electrophysiology median Middle half National median
2019 $47,509 $2,361 $585–$8,260 $163
2020 $39,608 $993 $247–$4,351 $114
2021 $43,399 $1,185 $326–$4,739 $132
2022 $5,790 $2,073 $554–$6,789 $149
2023 $9,564 $2,568 $759–$8,159 $160
2024 $6,346 $2,557 $703–$7,403 $164
2025 $13,094 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Preventice Services, LLC $99,000 5 payments
  2. Abbott Laboratories $34,281 578 payments
  3. Atricure, Inc. $12,449 28 payments
  4. Biotronik Inc. $4,136 3 payments
  5. Biosense Webster, Inc. $4,073 118 payments
  6. Medtronic, Inc. $3,278 55 payments
  7. Boston Scientific Corporation $2,665 64 payments
  8. Medical Device Business Services, Inc. $1,000 1 payment
  9. Respicardia, Inc. $888 4 payments
  10. Impulse Dynamics (USA) Inc. $821 11 payments
  11. Other $2,717 77 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $119,706 15 payments
  2. Food and Beverage $27,902 875 payments
  3. Travel and Lodging $9,363 45 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,000 1 payment
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,200 1 payment
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,513 2 payments
  7. Education $404 3 payments
  8. Debt forgiveness $158 1 payment
  9. Gift $65 1 payment
Products named General payments · program years 2019–2025
  1. BG Mini Plus $27,000 3 payments
  2. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $11,986 22 payments
  3. ATRICLIP LAA EXCLUSION SYSTEM $10,384 12 payments
  4. SYNERGY ABLATION SYSTEM $10,235 13 payments
  5. ISOLATOR SURGICAL ABLATION SYSTEM $10,087 10 payments
  6. DISSECTOR $10,087 10 payments
  7. TACTICATH ABLATION CATHETER, SENSOR ENABLED $7,095 6 payments
  8. Advisor Catheter $5,160 66 payments
  9. Carto 3 $4,429 95 payments
  10. ENSITE $3,054 68 payments
  11. Other $28,728 663 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abbott Laboratories $6,384 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

687

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$158,184

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

30.4%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 104 $111,267
Xarelto Rivaroxaban Brand 17 $25,637
Dofetilide Generic 55 $8,804
Flecainide Acetate Generic 94 $3,673
Metoprolol Succinate Generic 116 $3,232
Amiodarone Hcl Generic 54 $2,800
Sotalol Sotalol Hcl Brand 75 $1,115
Losartan Potassium Generic 34 $461
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 13 $377
Carvedilol Generic 37 $223

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$426,183

Medicare's payments for the services billed

Medicare patients

1,339

Average age 77

Services billed

10,085

580 women, 759 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 70%
Ischemic heart disease 63%
Heart failure 62%
Arthritis 48%
Diabetes 46%
Chronic kidney disease 44%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CAMZYOS
$48 — —
ONPATTRO
$23 — —
ELIQUIS
$20 104 —
VERQUVO
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

945 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record